Shares of Exactech Inc. (NASDAQ:EXAC) reached a new 52-week high during trading on Friday . The stock traded as high as $27.99 and last traded at $27.99, with a volume of 12,760 shares changing hands. The stock had previously closed at $27.29.

Several research firms have recently commented on EXAC. Zacks Investment Research raised shares of Exactech from a “hold” rating to a “buy” rating and set a $25.00 price target on the stock in a research note on Tuesday, April 19th. Robert W. Baird raised shares of Exactech from a “neutral” rating to an “outperform” rating and increased their price target for the company from $21.00 to $26.00 in a research note on Wednesday, April 13th.

The stock has a market cap of $399.09 million and a P/E ratio of 25.48. The firm has a 50 day moving average of $26.81 and a 200-day moving average of $22.49.

Exactech (NASDAQ:EXAC) last released its quarterly earnings data on Monday, August 1st. The company reported $0.31 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.30 by $0.01. During the same quarter in the prior year, the company earned $0.26 earnings per share. The company had revenue of $66.10 million for the quarter, compared to analyst estimates of $64.18 million. Exactech’s revenue for the quarter was up 7.5% compared to the same quarter last year. Equities research analysts anticipate that Exactech Inc. will post $1.18 EPS for the current year.

In related news, CFO Joel C. Phillips sold 3,000 shares of the company’s stock in a transaction that occurred on Friday, July 1st. The shares were sold at an average price of $26.75, for a total transaction of $80,250.00. Following the completion of the transaction, the chief financial officer now directly owns 101,632 shares in the company, valued at approximately $2,718,656. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Bruce E. Thompson sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 7th. The stock was sold at an average price of $25.07, for a total transaction of $50,140.00. Following the transaction, the senior vice president now owns 25,647 shares of the company’s stock, valued at $642,970.29. The disclosure for this sale can be found here.

An institutional investor recently raised its position in Exactech stock. Dimensional Fund Advisors LP boosted its position in shares of Exactech Inc. (NASDAQ:EXAC) by 6.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 557,024 shares of the company’s stock after buying an additional 34,863 shares during the period. Dimensional Fund Advisors LP owned approximately 3.96% of Exactech worth $10,110,000 as of its most recent filing with the SEC.

Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee implants, hip implants, biologics and spine, extremity implants and other products. Its other products segment includes surgical instruments, bone cement and other implant product lines.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.